Dr. Christy explains the data behind molnupiravir, the new oral drug for the treatment of COVID-19 from Merck. And she shares some pros and cons of the medication.

REFERENCES:
NHC mammalian mutagenic potential paper:
https://www.sciencedirect.com/science...